Literature DB >> 23550039

Tribbles in acute leukemia.

Kai Ling Liang1, Loveena Rishi, Karen Keeshan.   

Abstract

There is growing research interest in the mammalian Tribbles (Trib) family of serine/threonine pseudokinases and their oncogenic association with acute leukemias. This review is to understand the role of Trib genes in hematopoietic malignancies and their potential as targets for novel therapeutic strategies in acute myeloid leukemia and acute lymphoblastic leukemia. We discuss the role of Tribs as central signaling mediators in different subtypes of acute leukemia and propose that inhibition of dysregulated Trib signaling may be therapeutically beneficial.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23550039     DOI: 10.1182/blood-2012-12-471300

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.

Authors:  Karen Keeshan; Pauline Vieugué; Shahzya Chaudhury; Loveena Rishi; Coline Gaillard; Lu Liang; Elaine Garcia; Takuro Nakamura; Nader Omidvar; Scott C Kogan
Journal:  Haematologica       Date:  2016-07-06       Impact factor: 9.941

2.  GATA4 is a key regulator of steroidogenesis and glycolysis in mouse Leydig cells.

Authors:  Anja Schrade; Antti Kyrönlahti; Oyediran Akinrinade; Marjut Pihlajoki; Merja Häkkinen; Simon Fischer; Tero-Pekka Alastalo; Vidya Velagapudi; Jorma Toppari; David B Wilson; Markku Heikinheimo
Journal:  Endocrinology       Date:  2015-02-10       Impact factor: 4.736

3.  The complex relationship of Tribbles pseudokinase 1, PML/RARA and C/EBPα in leukemia: two possible couples but not a trio.

Authors:  Guillermo Velasco
Journal:  Haematologica       Date:  2016-10       Impact factor: 9.941

4.  Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndrome.

Authors:  Yan-Fung Wong; Chris N Micklem; Masataka Taguchi; Hidehiro Itonaga; Yasushi Sawayama; Daisuke Imanishi; Shinichi Nishikawa; Yasushi Miyazaki; Lars Martin Jakt
Journal:  Stem Cells Transl Med       Date:  2014-08-13       Impact factor: 6.940

5.  Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.

Authors:  Seiko Yoshino; Takashi Yokoyama; Yoshitaka Sunami; Tomoko Takahara; Aya Nakamura; Yukari Yamazaki; Shuichi Tsutsumi; Hiroyuki Aburatani; Takuro Nakamura
Journal:  Blood       Date:  2021-01-07       Impact factor: 22.113

6.  Targeting pseudokinase TRIB3 brings about a new therapeutic option for acute promyelocytic leukemia.

Authors:  Ke Li; Feng Wang; Zhuo-Wei Hu
Journal:  Mol Cell Oncol       Date:  2017-06-16

Review 7.  C/EBPα in normal and malignant myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2015-03-10       Impact factor: 2.490

8.  Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.

Authors:  Daniel M Foulkes; Dominic P Byrne; Wayland Yeung; Safal Shrestha; Fiona P Bailey; Samantha Ferries; Claire E Eyers; Karen Keeshan; Carrow Wells; David H Drewry; William J Zuercher; Natarajan Kannan; Patrick A Eyers
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 8.192

9.  Do TRIB1 and IL-9 Gene Polymorphisms Impact the Development and Manifestation of Pituitary Adenoma?

Authors:  Tomas Mickevicius; Alvita Vilkeviciute; Brigita Glebauskiene; Loresa Kriauciuniene; Rasa Liutkeviciene
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 10.  The Critical Role of TRIB2 in Cancer and Therapy Resistance.

Authors:  Victor Mayoral-Varo; Lucía Jiménez; Wolfgang Link
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.